Scabies
MONDO:0004525A contagious skin infection that is caused by the burrowing parasitic mite, Sarcoptes scabiei, and is characterized by intense itching and small, raised red spots in the area of the mite burrows.
Also known as: Sarcoptes scabiei caused disease or disorder, Sarcoptes scabiei disease or disorder, Sarcoptes scabiei infectious disease, sarcoptic itch
12 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a single pill cure scabies? new study tests three doses
Disease control CompletedThis study tested whether a single dose of an oral drug called moxidectin can cure scabies, a skin condition caused by tiny mites. 200 adults with confirmed scabies received either 8 mg, 16 mg, or 32 mg of moxidectin or a placebo. The main goal was to see if the drug could comple…
Phase: PHASE2 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common parasite drug help young kids with scabies?
Disease control CompletedThis study tested the safety and effectiveness of oral ivermectin for treating scabies in children weighing 5 to less than 15 kilograms. 240 children participated, receiving either ivermectin, a standard permethrin cream, or a placebo. The goal is to see if ivermectin can be a sa…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New ivermectin minitablets could treat scabies in infants and toddlers
Disease control CompletedThis completed Phase 2 trial tested oral ivermectin minitablets in 13 children aged 3 months and older weighing 5 to less than 15 kilograms who had scabies. The study aimed to check the safety, how the drug works in the body, and how well it treats the infection. Results will hel…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
One shot wonder? new antibiotic trial for Kids' skin infections
Disease control CompletedThis study tested a single dose of the antibiotic oritavancin in 118 children aged 3 months to 12 years with acute bacterial skin infections. The goal was to see if it is safe and tolerable. Researchers also looked at how the drug works in the body and whether it cures the infect…
Phase: PHASE2 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Scabies cure rates under the microscope: national study reveals treatment success
Knowledge-focused CompletedThis completed Italian study looked at over 1,300 people with scabies to see how often the first treatment cured them. Researchers also tracked how many scabies cases occurred over three years and analyzed patterns by age and ethnicity. The study did not test a new drug but colle…
Sponsor: Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC